— Open Aperture provides no-cost access to TfR1 CapX, a leading central nervous system-targeting AAV capsid — NEW YORK, NY – Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today announced the launch of Open Aperture, a material transfer agreement program that provides qualified academic researchers with access to […]
BOTHELL, Wash. — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain ctokine and growth factor products manufactured by Qkine for use in cell and […]
Appointments to bolster rapid scaling and execution of Pyxa™ spatial platform BOSTON — Stellaromics, a pioneer in high-resolution 3D spatial multi-omics, today announced the appointment of Stacie Weninger, PhD, and Steve McPhail to its Board of Directors. These strategic appointments come at a pivotal time for the company as it scales its innovative Pyxa™ technology and […]
Dr. Matt McManus to transition from his role as President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 Steve Crouse, Senior Vice President of Bio-Techne’s Analytical Solutions Division, has been appointed President, Diagnostics and Spatial Biology Segment, effective March 1, 2026 MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that Dr. Matt McManus, President […]
Schlieren, Switzerland — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed a partnership with PharmaNest Inc, a Princeton, NJ-based digital pathology company. This partnership uniquely positions InSphero’s in the space of the translational application of machine learning tools in combination with human pre-clinical models to decipher complex pathological phenotypes for the identification of effective therapies. A key challenge of these current unmet clinical needs is the prediction of the drug efficacy of complex fibrotic phenotypes in clinical stages. The […]
LEIDEN, the Netherlands — Today marks an important step for the global microphysiological systems (MPS) field with the launch of IAMPS – the Industry Alliance for Microphysiological Systems – the world’s first industry association dedicated to advancing MPS technologies. With MIMETAS as a founding member, IAMPS brings together nine pioneering companies – AlveoliX (Switzerland), BiomimX (Italy), chiron (Netherlands), Dynamic42 […]
Produces 35–500 liters of sterile media and buffers on demand at point-of-use, reducing cost, complexity, and lead times Pod-based, closed single-use system with integrated analytics, QR-code-driven execution, and automated digital batch records to support GMP-compliant manufacturing SAN DIEGO — Nucleus Biologics, a leading provider of custom cell culture solutions and manufacturing technologies for advanced therapies, […]
San Diego, CA — CellarisBio today announced the issuance of its flagship U.S. patent covering the MICRO-TAG® technology platform and the commercial launch of its first MICRO-TAG® reagent product line at the SLAS 2026 International Conference & Exhibition in Boston. These milestones position MICRO-TAG® as a real-time cellular target engagement platform for drug discovery across both […]
A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate Monmouth Junction, NJ — TheWell Bioscience today announced the launch of the VitroPrime™ 3D Culture and Imaging Plate, a next-generation 3D cell culture plate engineered to support organoid and advanced 3D cell culture workflows with minimal […]
TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery MADISON, Wis. — Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
